爱朋医疗：2024年研发投入3327.76万元，占营业收入8.24%

Core Viewpoint - The company disclosed its research and development (R&D) investment for 2024, indicating a focus on innovation despite being in the early stages of a new subsidiary [1] Summary by Categories R&D Investment - The total R&D investment for 2024 is reported to be 33.28 million yuan, which represents 8.24% of the company's operating revenue [1] Company Development - Shenzhen Pengrui Brain Science Technology Co., Ltd. was established in August 2024 and is currently in the initial investment phase [1]